Expert Q&A: OneLab—Pathology Meets Virtual Reality
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
Leanne Davey of Waters Corporation discusses recent technological trends in the clinical space with G2 managing editor Rachel Muenz.
A recent study provides insights on how to use automation and only 20 μL of a serum sample to quantify blood levels of antidepressants.
G2 Intelligence managing editor Rachel Muenz chats with lab leader Stephanie Whitehead about recent developments affecting clinical labs.
In the period from Mid-February through mid-March, three different products received first-of-their-kind clearances from the agency.
New technologies show potential for far greater accuracy and the ability to customize treatment options to improve outcomes.
The personalized test is designed to help inform post-surgery adjuvant therapies in CRC patients.
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.
Researchers found that combining AI with both imaging technologies can improve the detection of cancer in women with dense breasts.
According to the FDA’s recently-released annual report, only 135 devices received the designation last year, versus 213 in 2021.
A new method for early detection of 14 cancer types based on glycosaminoglycan profiles shows promise.